Limited time offer! 10% off your first blood test order!
AMH — the most reliable single-marker blood test for remaining ovarian reserve, measurable on any day of the cycle.
or 4 interest-free payments of £12.25 with Klarna
A single-marker AMH (anti-Mullerian hormone) test providing the most reliable blood-based estimate of remaining ovarian reserve.
Anti-Mullerian hormone (AMH) is produced by the granulosa cells of small growing follicles in the ovaries. Unlike FSH or oestradiol, AMH does not fluctuate significantly across the menstrual cycle and can be measured on any day — making it the most convenient and reliable single-marker indicator of ovarian reserve available.
AMH declines steadily with age as the egg pool diminishes, and reaches very low or undetectable levels in the years approaching menopause. A higher AMH indicates a larger remaining follicle pool; a lower AMH indicates a smaller reserve. This information is valuable for women planning their reproductive timeline, those considering egg freezing, and those who have been trying to conceive and want to understand whether ovarian reserve may be a factor.
AMH reflects egg quantity, not quality. A low result does not prevent natural conception; it means the window may be narrowing faster. Home fingerstick kit available for AMH. GMC-physician reviewed results within 3 to 5 working days.
Understand what each marker measures, why it matters, and what the science says — not just a list of numbers.
Produced by small growing follicles; the most stable and reliable blood-based marker of remaining egg supply.
This panel is designed for adults who want a comprehensive, evidence-based picture of their metabolic health — not a GP referral panel.
Women aged 25 to 45 wanting to understand their reproductive timeline
Those considering egg freezing who want to know their ovarian response potential
Women who have been trying to conceive and want to check their egg supply
Those planning to delay pregnancy and wanting a fertility checkpoint
AMH reflects the quantity of remaining eggs, not their quality. Egg quality is the dominant determinant of conception success in women over 35 and cannot be measured by a blood test. A low AMH does not mean you cannot conceive naturally or with IVF; and a normal AMH does not guarantee conception. AMH can be suppressed by recent or current use of hormonal contraception — for the most accurate baseline, testing 3 or more months after stopping hormonal contraception is advisable. AMH is also influenced by vitamin D status and smoking, and may be slightly higher in women with PCOS. Results should be interpreted in the context of age and clinical history by a qualified physician.
From order to physician-reviewed report in as little as three working days.
Three options designed to fit your schedule, location, and preference — all producing a laboratory-standard sample.
Adults 18+ in mainland UK. Not suitable if you have had a transfusion in the last 3 months.
Order anytime; kit dispatched within 24 hours Mon–Fri.
Allow 24–48 hours for sample transit on top of lab processing time.
Adults 18+ within 20 miles of a serviced city centre.
Mon–Sun, 06:00–20:00. Next-day booking typical.
Sample reaches the lab within 24 hours of collection.
Adults 16+ with photo ID. Paediatric draws by appointment at selected sites.
Mon–Fri, with Saturday hours at most metropolitan locations.
Samples processed same-day at the receiving clinic.
Every test is processed in a UKAS ISO 15189-accredited laboratory, overseen by GMC-registered physicians, and governed by UK GDPR. No overseas processing, no offshore data.
Follow these guidelines to ensure accurate, reproducible results. Most markers are sensitive to recent food, exercise, and sleep.
Can't find your answer? Our clinical support team is available Monday to Friday, 9am–5pm.
Contact supportAMH and FSH measure different aspects of ovarian reserve. FSH measures how hard the pituitary is working to stimulate the ovaries — it rises when the ovaries become less responsive. AMH is produced directly by the ovarian follicles and reflects the actual remaining pool size. AMH has several advantages over FSH: it can be tested at any cycle day (FSH must be on days 2 to 5), it declines earlier and more predictably with age, and it is more sensitive at identifying reduced reserve before FSH becomes elevated. Both are useful, but AMH tends to be the more informative first-line test for ovarian reserve.
AMH declines gradually over time as part of the natural ageing process — typically by around 5 to 10% per year. This means that testing earlier gives you a longer timeline to make reproductive decisions. Regular testing (every 12 to 18 months) during the late 20s and 30s can reveal whether your AMH is declining faster than expected for your age. However, AMH does not change significantly from month to month based on lifestyle factors alone, so there is no need to test more frequently than annually in most circumstances.
Yes. Hormonal contraception, particularly combined oral contraceptives, has been shown to suppress AMH by 20 to 30% in some studies, though this effect is reversible on stopping. If you are currently on or have recently stopped hormonal contraception, your AMH result may be lower than your true baseline. For the most accurate reflection of your underlying ovarian reserve, we recommend testing at least 3 months after stopping hormonal contraception. If you are on the pill long-term and need an indication of your reserve, your physician report will note the likely suppression effect and contextualise the result accordingly.
No. A low AMH is useful information, not a definitive prognosis. Many women with low AMH conceive naturally. What it tells you is that your egg supply is smaller than average for your age, which means conception may take longer or may be more time-sensitive than for women with higher AMH. Women with low AMH who pursue IVF typically respond less well to ovarian stimulation (producing fewer eggs per retrieval cycle), but one good-quality egg is all that is needed for a successful cycle. Your physician report will interpret your result in the context of your age and provide balanced, evidence-based guidance — not alarmist conclusions.
AMH reflects the size of the follicle pool, which is largely fixed by genetics and declines with age — it cannot be meaningfully increased. However, certain factors can temporarily suppress AMH (hormonal contraception, smoking, vitamin D deficiency) and removing these suppressants can allow AMH to return to its natural level. Stopping smoking, correcting vitamin D deficiency, and ensuring a healthy body weight are all steps that support optimal ovarian function within your genetic reserve. No supplement has been proven to increase AMH in clinical trials. Be sceptical of any product claiming to ‘boost’ AMH.
AMH is one of the key factors fertility clinics use to assess suitability and likely response to egg freezing (oocyte cryopreservation). Women with higher AMH typically produce more eggs per stimulation cycle, giving a better bank of frozen eggs per retrieval attempt. Women with lower AMH may produce fewer eggs and may need multiple cycles. However, the decision to pursue egg freezing involves medical, personal, financial, and practical considerations beyond AMH alone — including age, relationship status, career, and personal values. Your Trupoint Health physician report will discuss what your AMH result means in the context of fertility planning, and recommend whether a fertility clinic consultation is advisable.
